Products and Resources Catalog

2020 Back to the Future, A New Decade in Prevention! Additional Resources What's Happening Around the Region? Epi Corner: Broadening the Lens of Prevention

Opioid Overdoses and Suicide Additional Resources PTTC Events and Products Epi Corner:Understanding Disease Using the Epidemiology Triangle

Upcoming PTTC Training Brain Science Techniques and Tobacco Control Measures: A Merging of the Minds   Five Fascinating Brain Science Resources

Upcoming PTTC Training Serving Military Veterans in Substance Misuse Prevention Additional Resources Question to the Field Apps for Veterans and Those Working With Veterans Addressing Trauma  

What is the Value of Prevention Credentialing? International Certification & Reciprocity Consortium Prevention Examination and Domains Testing Resources Region 6 Credentialing Boards Degree Programs in Prevention What's Happening Around the Region? Epi Corner: Growing and Maintaining a Competent Prevention Workforce: A Data Driven Process

  Congratulations SAMHSA Grantees Resources-New Fiscal Year Training and Conference Highlights Staff Music Picks Staff Self-Care Ideas Epi Corner-Partnering with an Epidemiologist to Enhance Your Prevention Efforts

Central East Webinar Series: Preventing Youth Vaping Part 1: The Extent and Risk Factors for Youth Vaping Josh Esrick, MPP, and Emily Patton, MSc, PgDip June 25, 2020, 1-2 PM EST  |  View all Central East series This is part one of a two-part webinar series hosted by the Central East PTTC that focuses on preventing youth vaping and related topics. COURSE DESCRIPTION This webinar will examine data on the rise and scope of vaping, and how it contrasts with previous tobacco use data. It will also examine the known risk factors that contributed to this rise, such as ease of availability, low perceptions of harm, and lack of environmental strategies to prevent use. The webinar will also discuss the issue and current status of acute lung injuries caused by vaping. LEARNING OBJECTIVES Explain the importance of youth vaping as a prevention priority Explore prevalence data on vaping and tobacco product use Discuss known risk factors for vaping use Identify areas where further research is require PRESENTERS Josh Esrick, MPP is a Senior Policy Analyst with Carnevale Associates. Josh has extensive experience in substance use prevention; researching, writing, and presenting on best practice and knowledge development publications, briefs, and reference guides; and developing and providing T/TA to numerous organizations. He developed numerous SAMHSA Center for the Application of Prevention Technologies’ (CAPT) products on strategies to prevent opioid misuse and overdose, risk and protective factors for substance use, youth substance use prevention strategies, youth substance use trends, emerging substance use trends, the potential regulations surrounding marijuana legalization, as well as numerous other topics. Emily Patton, MSc, PgDip holds a Masters of Science in Abnormal and Clinical Psychology from Swansea University and a Postgraduate Degree in Criminology and Criminal Justice from the University of Edinburgh. She offers significant professional experience in the fields of public policy development and analysis, criminal justice research, data collection and analysis, program development, and performance management.               

The third edition of our bi-monthly newsletter is available. This month's edition features an update from the director, toolkit for parks and recreation, regionally and nationally developed trainings and tools to support and grow the prevention workforce in New England.

Today we will be talking with Crystal Fuller. Crystal provides Training, TA, funding administration, and helping prevention spread throughout her region in Nebraska. She has over 13 years working in prevention and shared insights on getting out into the community in this virtual world. We also get into the importance of self-care in days filled with Zoom after Zoom meeting.

Demystifying Data: Gathering and Using Local Risk and Protective Factor Data for Prevention - Part 2   Description Part II – Using Data. During this second webinar in the two-part series, we will discuss data quality and quantity – having enough data, and having the right data. Processes for prioritizing risk and protective factors to determine which to address with prevention efforts will be described, and examples will be shared. This webinar will conclude with recommendations for ongoing monitoring to inform evaluation efforts.  By the end of the webinar, participants will: learn tips for assessing the quality and quantity of the data they’ve gathered to determine readiness for prioritization and planning. identify prioritization processes, including how to format your data, prioritization dimensions to consider, and tips for making the process interactive and engaging, and understand the importance of ongoing data gathering and collection in order to evaluate local prevention efforts.   Presenter Melissa Adolfson, MS, is a Research Scientist with the Amherst H. Wilder Foundation. In this role, she provides research and evaluation services for clients addressing substance use, mental health, and community safety and connectivity. This work includes evaluating the efforts of six Drug Free Community grantees in Minnesota as well as Minnesota’s Partnership for Success and SPF Rx efforts. She has more than a decade of experience working with government and non-profit agencies at the local, state, tribal, and federal levels to collect, analyze, interpret, disseminate, and use data for prevention efforts.   Webinar Recording View Webinar   Webinar Slides Download Slides - Demystifying Data: Gathering and Using Local Risk and Protective Factor Data for Prevention - Part 2  

Developed by the PTTC Evidence-Based Interventions Workgroup, this one page (front and back) handout serves as a quick guide for adapting evidence-based interventions including why, how, and where to adapt and things to consider.    

Webinar: Resources for Supporting the Mental Health and Well-being of Children and Families During COVID-19   DATE: June 11, 2020   DESCRIPTION: These are difficult times for many families struggling to cope with job losses or working from home while managing the added responsibility of child care and home schooling. This webinar will focus on the mental health and well-being of children and families during the COVID-19 pandemic and the early data that provides insight into the challenges and opportunities for substance misuse prevention practitioners to support families and communities during this time. The webinar will also highlight many of the resources available from Child Trends, the nation’s leading research organization focused exclusively on improving the lives of children and youth, especially those who are most vulnerable. The webinar will also discuss how these resources can be applied in your agency and community setting.   PRESENTER: Jessica Dym Bartlett, M.S.W., Ph.D., is Program Director of Early Childhood Research at Child Trends. She conducts evaluation and applied research on interventions to promote the emotional and relational well-being of children and families exposed to trauma and adversity, including child abuse and neglect, child and parent mental health problems, and natural disasters, with a focus on prevention and promotion of resilience. Dr. Bartlett is Principal Investigator (PI) of a randomized controlled trial (RCT) on the impact of the Newborn Behavioral Observations on maternal mental health and mother-infant relationships at Harvard Medical School, lead evaluator for the Child Trauma Training Center at the University of Massachusetts Medical School, and developer of a toolkit to mitigate childhood trauma in the face of disasters and pandemics.   WEBINAR SLIDES: Download Slides - Resources for Supporting the Mental Health and Well-being of Children and Families During COVID-19 (PDF)   OTHER RESOURCES: ChildTrends.org

These are the handouts and materials used during the presentation.

The primary function of any coalition structure is to bring together community resources for a common goal, but how can that be done during a pandemic? How do we keep coalition stakeholders and members engaged when in-person meetings are not an option? As many worry about increased levels of substance misuse while people shelter in place, and that increased misuse could continue beyond the COVID-19 pandemic, continuing to engage coalition members and maintain momentum is critical.

While racism and classism are not exclusive to the United States, the American paradigm is unique due to its history of slavery, conquest, and immigration.  Each new wave of immigrants to America has experienced systematic inequality in a system based on ethnic and racial oppression. The pressure of conforming and confronting this system produces stress and mental anguish, which primarily afflicts minority communities.  In the recorded presentation Liberty, Humiliation, and Identity: Race and the Suffering of America, Albert Thompson will cover how to engage in a dialogue about physical and mental health that encompasses societal morbidity. We will examine how particular events in our history demonstrate the consequences of racial views and our need to listen and engage. Behavioral health providers must consider race and the impact it has on leadership. Change leaders need to be politically and socially knowledgeable, listen, and understand a broader perspective of historical foreign and domestic policy related to race, ethnicity, and culture. To gain the agility necessary to navigate within an ever-growing diverse population in need of mental health and addiction services in our country, we must consider elevating skills that transcend culture and human-made racial boundaries.

The major focus of this online course is to discuss how opioid misuse and overdose prevention strategies can be coordinated with efforts around infectious disease control in order to improve data collection, align resources, increase access to focus populations, and address shared risk and protective factors. By the end of this course, participants will be able to: 1. Describe the current intersections between the opioid epidemic and the increases in infectious disease. 2. Share evidence-based and promising interventions for addressing the epidemic. 3. Identify potential roles for prevention practitioners. 3.0 Hour Certificate of Completion Available

Join us for the first offering in this informative pharmacology course series. This course will explore the pharmacology of alcohol. The presenter will cover how alcohol addiction impacts major brain regions and the acute and chronic symptoms associated with alcohol use. Specific features of alcohol dependence and withdrawal will be discussed. Additionally, we will discuss alcohol use during pregnancy and the categories of Fetal Alcohol Spectrum Disorder (FASD). By the end of this course, participants will be able to: 1. Define alcohol addiction and list the components that influence stigma. 2. Describe the acute and chronic effects of alcohol use. 1.5 Hour Certificate of Completion Available

This course will explore the pharmacology of opioids. The presenter will cover how opioid addiction impacts major brain regions and the acute and chronic symptoms associated with opioid use. Specific features of opioid dependence and withdrawal will be discussed specifically symptoms that occur when a person is discontinuing their use. By the end of this course, participants will be able to: 1. Define addiction and how it impacts regions of the brain. 2. Describe the acute and chronic effects of opioid use and withdrawal. 1.5 Hour Certificate of Completion Available

Join us for the third offering in our pharmacology course series. This course will explore the pharmacology of psychostimulants with a focus on cocaine and methamphetamines. The presenter will cover how psychostimulant addiction impacts major brain regions and the acute and chronic symptoms associated with cocaine and methamphetamine use. Specific features of psychostimulant dependence and withdrawal will be discussed specifically symptoms that occur when a person is discontinuing their use. By the end of the course, participants will be able to: 1. Define addiction and how it impacts regions of the brain. 2. Describe the acute and chronic effects of cocaine and methamphetamine use and withdrawal. 1.5 Hour Certificate of Completion Available

Join us for the fourth and final offering in our pharmacology course series. This course will explore the pharmacology of cannabis. The presenter will cover how cannabis addiction impacts major brain regions and the acute and chronic symptoms associated with cannabis use. Specific features of cannabis dependence and withdrawal will be discussed specifically symptoms that occur when a person is discontinuing its use. By the end of this course, participants will be able to: 1. Define addiction and how it impacts regions of the brain. 2. Describe the acute and chronic effects of cannabis use and withdrawal. 1.5 Hour Certificate of Completion Available

The major focus of this online course is to discuss how opioid misuse and overdose prevention strategies can be coordinated with efforts around infectious disease control in order to improve data collection, align resources, increase access to focus populations, and address shared risk and protective factors. By the end of this course, participants can expect to be able to: Describe the current intersections between the opioid epidemic and the increases in infectious disease. Share evidence-based and promising interventions for addressing the syndemic. Identify potential roles for prevention practitioners.

This course will explore the pharmacology of opioids. The presenter will cover how opioid addiction impacts major brain regions and the acute and chronic symptoms associated with opioid use. Specific features of opioid dependence and withdrawal will be discussed specifically symptoms that occur when a person is discontinuing their use. OBJECTIVES By the end of the course, participants will be able to: Define addiction and how it impacts regions of the brain. Describe the acute and chronic effects of opioid use and withdrawal     Ron Jackson, MSW, LICSW, is a Clinical Professor at the University of Washington’s School of Social Work where he teaches courses on addiction and its treatment methods. He recently retired as the Executive Director of Evergreen Treatment Services (ETS), a private non-profit organization, in Seattle, Washington, that provides outpatient opioid treatment in clinics in western Washington and street-based case management services for homeless persons with substance misuse disorders (REACH Program) in Seattle. He served for 10 years as a Co-Principal Investigator for the Washington Node of NIDA’s Clinical Trials Network and is currently on the Advisory Board for the NWATTC.  Mr. Jackson has worked in the field of addiction treatment since 1972.

Our webinar for June 10th 2020: Screening, Brief Intervention, and Referral to Treatment (SBIRT) Training is available for viewing at the link above!

Produced by the Central East Prevention Technology Center, this Suicide Prevention Resource Guide is intended to support suicide prevention stakeholders and other interested individuals by providing a comprehensive list of suicide prevention resources, as of April 2020. These suicide prevention hotlines and other resources contained in this document are located within the Central East Region (i.e., Delaware, Maryland, Pennsylvania, Virginia, West Virginia, and the District of Columbia). The document is organized into two primary sections: National hotlines and resources developed or supported by the Substance Abuse and Mental Health Services Administration (SAMHSA), other Federal agencies, or national nonprofit organizations. State-specific hotlines and resources developed by state agencies or statewide or local nonprofit organizations.